Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PKS Holdings is a health information services business based in Australia. PKS Holdings shares (PKS) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. PKS Holdings has a trailing 12-month revenue of around $6 million. If you're looking to buy shares, check out the steps below.
|52-week range||$0.4 - $0.7|
|50-day moving average||$0.4807|
|200-day moving average||$0.4141|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.002|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 year (2021-07-05)||33.33%|
|2 years (2020-07-03)||251.52%|
|3 years (2019-07-05)||222.22%|
Valuing PKS Holdings stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PKS Holdings 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PKS Holdings 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 275x. In other words, PKS Holdings shares trade at around 275x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PKS Holdings 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $289,974 (£164,756).
The EBITDA is a measure of a PKS Holdings 's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6 million|
|Gross profit TTM||$2.9 million|
|Return on assets TTM||-0.79%|
|Return on equity TTM||1.1%|
|Market capitalisation||$124 million|
TTM: trailing 12 months
We're not expecting PKS Holdings to pay a dividend over the next 12 months.
Over the last 12 months, PKS Holdings 's shares have ranged in value from as little as $0.4 up to $0.7. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while PKS Holdings 's is 1.8023. This would suggest that PKS Holdings 's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally. The company offers RippleDown Expert, an CDS system that provides real-time patient monitoring, alerting, data mining, and reporting capability; and RippleDown Auditor, a knowledge based system that allows various departments within a laboratory, including data entry, billing, and specimen reception to audit data in real-time. It also provides LabQ, a data mining tool; PICQ, an auditing tool used in hospital that assesses every record clinically coded for data quality; RISQ to provide industry benchmark of hospital-acquired complications incidence and underlying data quality; and Codexpert, a web-based eBook application providing the full health-data classification reference for clinical coding of patient episodes. The company serves customers through direct sales and channel partners. The company was formerly known as QPro Holdings Limited. PKS Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.